United States Genomics Market Growth, Demand and Challenges of the Key Industry Players 2024-32

1
United States Genomics Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• IMARC Group is a global management consulting
  firm that helps the worlds most ambitious
  changemakers to create a lasting impact. Across
  the six major continents and 100 countries, we
  work alongside our business partners as one team
  with a common ambition to achieve unparalleled
  results, gain a competitive edge, and transform
  industries. IMARC Group excels in understanding
  its clients business priorities and delivering
  tailored solutions that drive meaningful
  outcomes. Our client base spans over 3,000
  organizations in the private, public, and social
  sectors, ranging from high-growth startups to
  Fortune 500 companies.
• We provide a comprehensive suite of market entry
  and expansion services. Our offerings include
  thorough market assessment, feasibility studies,
  company incorporation assistance, factory setup
  support, regulatory approvals and licensing
  navigation, branding, marketing and sales
  strategies, competitive landscape and
  benchmarking analyses, pricing and cost research,
  and procurement research. These services are
  designed to assist companies in evaluating market
  opportunities, setting up new entities,
  navigating regulatory landscapes, boosting brand
  visibility, analyzing competitors, and optimizing
  procurement strategies.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "United States Genomics Market Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2024-2032," the United States genomics
  market size is projected to exhibit a growth rate
  (CAGR) of 19.60 during ?2024-2032?.
• Over the past two decades, the development of
  next-generation sequencing (NGS) technologies has
  revolutionized the field of genomics by enabling
  the rapid, accurate, and cost-effective
  sequencing of entire genomes. These advancements
  have significantly lowered the cost of sequencing
  a human genome from billions of dollars to less
  than 1,000, making genomic data more accessible
  to researchers, healthcare providers, and
  patients. This democratization of genomic
  information has spurred a surge in genomic
  research, personalized medicine, and consumer
  genomics. Researchers can now conduct large-scale
  genomic studies, leading to the discovery of new
  genetic markers and the development of targeted
  therapies for various diseases. In the clinical
  setting, affordable genomic sequencing has paved
  the way for precision medicine, where treatments
  and preventive strategies are tailored to the
  individual genetic profiles of patients,
  improving outcomes, and reducing adverse effects.
  Another crucial factor driving the United States
  genomics market is the growing integration of
  genomics into healthcare and the increasing
  demand for personalized medicine. The rise of
  precision medicine, which focuses on customizing
  healthcare based on an individuals genetic
  makeup, lifestyle, and environment, is
  fundamentally altering the landscape of medical
  treatment.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/united-states-genomics-
  market/requestsample

4
Report Description

• United States Genomics Market Trends
• The increasing adoption of genomics in healthcare
  is supported by significant investments from both
  the public and private sectors. The National
  Institutes of Health (NIH) and other government
  agencies have launched large-scale initiatives,
  such as the All of Us Research Program, aimed at
  gathering genetic data from diverse populations
  to advance our understanding of health and
  disease. These programs not only drive scientific
  discovery but also build infrastructure and
  create databases that facilitate further research
  and clinical applications.
• In the private sector, pharmaceutical and
  biotechnology companies are investing heavily in
  genomics to accelerate drug discovery and
  development. Collaborations between industry,
  academia, and healthcare providers are fostering
  innovation and translating genomic research into
  clinical practice. Regulatory support and the
  establishment of ethical guidelines also play a
  vital role in driving the genomics market. The
  U.S. Food and Drug Administration (FDA) and other
  regulatory bodies are working to create
  frameworks that ensure the safe and effective use
  of genomic technologies in healthcare.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/united-states-genomics-
  market

5
Report Segmentation

• Component Insights
• Products
• Instruments and Software
• Consumables and Reagents
• Services
• Core Genomics Services
• NGS-Based Services
• Biomarker Translation Services
• Computational Services
• Others
• Technology Insights
• Sequencing
• Microarray
• Polymerase Chain Reaction

6
Report Segmentation

• Nucleic Acid Extraction and Purification
• Others
• Application Insights
• Functional Genomics
• Epigenomics
• Biomarkers Discovery
• Pathway Analysis
• Others
• End User Insights
• Research Centers
• Hospitals and Clinics

7
Report Segmentation

• Pharmaceutical and Biotechnology Companies
• Others
• Regional Insights
• Northeast
• Midwest
• South
• West

8
Key Questions Answered in the Report
9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4 United
  States Genomics Market - Introduction
• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence
• 5 United States Genomics Market Landscape
• 5.1 Historical and Current Market Trends
  (2018-2023)
• 5.2 Market Forecast (2024-2032)
• 6 United States Genomics Market - Breakup by
  Component
• 6.1 Products
• 6.1.1 Overview
• 6.1.2 Historical and Current Market
  Trends (2018-2023)
• 6.1.3 Market Segmentation
• 6.1.3.1 Instruments and Software
• 6.1.3.2 Consumables and Reagents
• 6.1.4 Market Forecast (2024-2032)     
   

11
Table of Contents

• 6.2 Services
• 6.2.1 Overview
• 6.2.2 Historical and Current Market
  Trends (2018-2023)
• 6.2.3 Market Segmentation
• 6.2.3.1 Core Genomics Services
• 6.2.3.2 NGS-Based Services
• 6.2.3.3 Biomarker Translation Services
• 6.2.3.4 Computational Services
• 6.2.3.5 Others
• 6.2.4 Market Forecast (2024-2032)
• 7 United States Genomics Market - Breakup by
  Technology
• 7.1 Sequencing
• 7.1.1 Overview
• 7.1.2 Historical and Current Market
  Trends (2018-2023)
• 7.1.3 Market Forecast (2024-2032)
• 7.2 Microarray
• 7.2.1 Overview
• 7.2.2 Historical and Current Market
  Trends (2018-2023)
• 7.2.3 Market Forecast (2024-2032)

12
Partial List of Clients
13
Partial List of Clients
14
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

15
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us